Clark Estates Inc. NY Increases Stock Holdings in CVS Health Co. (NYSE:CVS)

Clark Estates Inc. NY boosted its position in shares of CVS Health Co. (NYSE:CVS) by 19.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,375 shares of the pharmacy operator’s stock after acquiring an additional 7,500 shares during the period. Clark Estates Inc. NY’s holdings in CVS Health were worth $2,037,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health during the 3rd quarter valued at $25,000. Legacy Investment Solutions LLC bought a new stake in CVS Health during the third quarter valued at $31,000. Ridgewood Investments LLC increased its stake in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the last quarter. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health in the 4th quarter valued at about $28,000. Finally, RPg Family Wealth Advisory LLC bought a new stake in shares of CVS Health during the 3rd quarter valued at about $40,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the topic of several research analyst reports. Barclays upped their price objective on shares of CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. UBS Group lowered their price objective on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 11th. Wolfe Research upped their target price on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 11th. TD Cowen raised their price target on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Finally, Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $69.83.

CVS Health Stock Performance

Shares of NYSE:CVS opened at $64.26 on Wednesday. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The company has a market cap of $81.01 billion, a price-to-earnings ratio of 17.56, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a 50-day moving average price of $55.14 and a 200-day moving average price of $56.58.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, equities analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.14%. CVS Health’s dividend payout ratio (DPR) is 72.68%.

Insider Activity

In related news, Director Michael F. Mahoney bought 30,000 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the purchase, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.24% of the stock is currently owned by company insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.